Evidence map›Paper›PMID 35673439›Full record

ArticleJournal of diabetes and metabolic disorders2022

The Persian version of the 8-item Morisky Medication Adherence Scale (MMAS-8): can we trust it?

Aida Iranpour, Vida Sarmadi, Arshia Alian Mofrad, Seyed Ali Mousavinezhad, Seyedeh Maryam Mousavinezhad, Fatemeh Mohammad Alizadeh, Sina Neshat

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Aida IranpourDepartment of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Vida SarmadiIsfahan University of Medical Sciences, 81746- 73461 Isfahan, Iran.
Arshia Alian MofradDepartment of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Seyed Ali MousavinezhadStudent Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.
Seyedeh Maryam MousavinezhadStudent Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Fatemeh Mohammad AlizadehGilan University of Medical Sciences, Rasht, Iran.
Sina NeshatIsfahan University of Medical Sciences, 81746- 73461 Isfahan, Iran.ORCID 0000-0001-6522-1865
Ahvaz Jundishapur University of Medical Sciences · IRIran University of Medical Sciences · IRIsfahan University of Medical Sciences · IRGuilan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetes mellitus (DM) is a common serious health problem. Medication adherence is a crucial determinant of therapeutic success in patients with diabetes mellitus. This study aims to examine the 8-item Morisky Medication Adherence Scale (MMAS-8) psychometric properties among diabetic patients. Methods: This study was carried out at the Internal Medicine clinic of Firooz Abadi Hospital in Tehran, Iran, from 2018 to 2020. The English version of the MMAS-8 was translated into Persian and administered to patients with diabetes mellitus. A total of 150 patients who had diabetes were included. Cronbach's alpha was calculated to assess the reliability. Results: According to the recommended scoring method, the Mean ± SD of MMAS-8 scores was 4.97 ± 1.92. Good internal consistency was found in our study (Cronbach's α = 0.70). Not any significant relationship between MMAS-8 categories and occurrence of complications was found. Conclusions: The findings of this validation study indicate that the Persian version of the MMAS-8 is a reliable measure of medication adherence, but it has not acceptable validity. Further studies are needed to reach a good validity.

Indexed as

AdherenceIranMorisky scalePersianType 2 diabetesValidation

Identifiers

PMID35673439
PMCPMC9167175
OpenAlexW4281391437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.